Effects of advanced glycation end products‐inductor glyoxal and hydrogen peroxide as oxidative stress factors on rat retinal organ cultures and neuroprotection by UK‐14,304

Retinal ganglion cell degeneration is supposed to be mediated by reactive oxygen species (ROS) and advanced glycation end products (AGEs). The alpha2‐adrenergic agonist, 5‐bromo‐N‐(4,5‐dihydro‐1H‐imidazol‐2‐yl)‐6‐quinoxalinamine (brimonidine; UK‐14,304), is said to exert a neuroprotective effect. To investigate these mechanisms in detail, we exposed rat whole mounts to glyoxal or H2O2 and treated them with either UK‐14,304 alone or additionally with the phosphatidylinositide 3 kinase (PI3) kinase inhibitor, 2‐(4‐Morpholinyl)‐8‐phenyl‐4H‐1‐benzopyran‐4‐one (Ly 294002). The accumulation of Nε‐[carboxymethyl] lysine (CML) was assessed immunohistochemically and changes in intracellular pH (pHi), mitochondrial transmembrane potential (MTMP) and ROS production in cell bodies of multipolar ganglion cell layer were studied by intravital fluorescence microscopy and confocal laser scanning microscopy. Ultrastructural changes in mitochondria of multipolar ganglion cell layer cell bodies were determined by transmission electron microscopy. We found that glyoxal and H2O2 increased accumulation of CML‐modified proteins and ROS production and decreased pHi and MTMP in cell bodies of multipolar ganglion cell layer. UK‐14,304 could prevent production of ROS, accumulation of CML‐modified proteins, ameliorate acidification, preserve MTMP and attenuate ultrastructural damages of ganglion cell mitochondria. Ly 294002 reversed the UK‐14,304‐mediated attenuation of CML and ROS production. We conclude that the protective effects of UK‐14,304 seem partly to be mediated by PI3 kinase‐dependent pathways.

[1]  R. Lai,et al.  Neuroprotection: new pharmacological targets , 2007, Eye.

[2]  Stefan Schinkinger,et al.  Müller cells are living optical fibers in the vertebrate retina , 2007, Proceedings of the National Academy of Sciences.

[3]  K. Abu-Amero,et al.  Mitochondrial abnormalities in patients with LHON-like optic neuropathies. , 2006, Investigative ophthalmology & visual science.

[4]  G. Tezel.  Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences , 2006, Progress in Retinal and Eye Research.

[5]  E. Sullivan,et al.  The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1. , 2006, Ophthalmology.

[6]  C. Chiquet,et al.  Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea , 2006, British Journal of Ophthalmology.

[7]  M. Rosner,et al.  A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. , 2006, American journal of ophthalmology.

[8]  K. Abu-Amero,et al.  Mitochondrial abnormalities in patients with primary open-angle glaucoma. , 2006, Investigative ophthalmology & visual science.

[9]  L. Levin,et al.  Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. , 2006, Investigative ophthalmology & visual science.

[10]  R. Funk,et al.  Inhibition of apoptosis and reduction of intracellular pH decrease in retinal neural cell cultures by a blocker of carbonic anhydrase. , 2006, Investigative ophthalmology & visual science.

[11]  N. Osborne,et al.  A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies , 2006, British Journal of Ophthalmology.

[12]  C. Opere,et al.  Pharmacological consequences of oxidative stress in ocular tissues. , 2005, Mutation research.

[13]  M. Avilés-Trigueros,et al.  Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine. , 2005, Investigative ophthalmology & visual science.

[14]  D. Butterfield,et al.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.

[15]  Alan W. Stitt.  The Maillard Reaction in Eye Diseases , 2005, Annals of the New York Academy of Sciences.

[16]  K. Baidya,et al.  The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus. , 2004, Journal of the Indian Medical Association.

[17]  Xiangjun Yang,et al.  Caspase-independent component of retinal ganglion cell death, in vitro. , 2004, Investigative ophthalmology & visual science.

[18]  Dean P. Jones,et al.  Cysteine starvation activates the redox-dependent mitochondrial permeability transition in retinal pigment epithelial cells. , 2004, Investigative ophthalmology & visual science.

[19]  R. Funk,et al.  [Characteristic features of optic nerve ganglion cells and approaches for neuroprotection. From intracellular to capillary processes and therapeutic considerations]. , 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[20]  R. Funk,et al.  Besonderheiten der Optikusganglienzellen und Ansätze zur Neuroprotektion , 2004, Der Ophthalmologe.

[21]  A. Martinuzzi,et al.  Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. , 2004, Biochimica et biophysica acta.

[22]  Brian Herman,et al.  Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm) , 2004, Brain Research Bulletin.

[23]  N. Osborne,et al.  Retinal ischemia: mechanisms of damage and potential therapeutic strategies , 2004, Progress in Retinal and Eye Research.

[24]  Dean P. Jones,et al.  The Coenzyme Q10 Analog Decylubiquinone Inhibits the Redox-activated Mitochondrial Permeability Transition , 2003, Journal of Biological Chemistry.

[25]  J. Lavoie,et al.  Effect of voluntary exercise on H2O2 release by subsarcolemmal and intermyofibrillar mitochondria. , 2003, Free radical biology & medicine.

[26]  R. Rosenstein,et al.  Retinal oxidative stress induced by high intraocular pressure. , 2003, Free radical biology & medicine.

[27]  C. Grimaldi,et al.  Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement , 2003, Journal of leukocyte biology.

[28]  R. Lai,et al.  Role of alpha-2 agonists in neuroprotection. , 2003, Survey of ophthalmology.

[29]  E. Schleicher,et al.  Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[30]  R. Funk,et al.  Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular and increase of intracellular pH in rat retinal organ culture , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[31]  T. Wieloch,et al.  Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria , 2003, Brain Research.

[32]  G. Seigel,et al.  Alteration of the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing agent glyoxal , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[33]  D. Bonnefont-Rousselot.  Glucose and reactive oxygen species , 2002, Current opinion in clinical nutrition and metabolic care.

[34]  R. Lai,et al.  Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat , 2002, Visual Neuroscience.

[35]  A. Terzic,et al.  Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. , 2002, American journal of physiology. Heart and circulatory physiology.

[36]  S. Pervaiz,et al.  A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. , 2002, Biochemical and biophysical research communications.

[37]  M. Madesh,et al.  VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release , 2001, The Journal of cell biology.

[38]  Alan W. Stitt,et al.  Advanced glycation: an important pathological event in diabetic and age related ocular disease , 2001, The British journal of ophthalmology.

[39]  S. Pervaiz,et al.  Intracellular Acidification Triggered by Mitochondrial-derived Hydrogen Peroxide Is an Effector Mechanism for Drug-induced Apoptosis in Tumor Cells* , 2001, The Journal of Biological Chemistry.

[40]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[41]  Christian Renken,et al.  Preservation of Mitochondrial Structure and Function after Bid- or Bax-Mediated Cytochrome c Release , 2000, The Journal of cell biology.

[42]  J. Martinou,et al.  Cytochrome c release from mitochondria: all or nothing , 2000, Nature Cell Biology.

[43]  T. Gardner,et al.  Retinal neurodegeneration: early pathology in diabetes , 2000, Clinical & experimental ophthalmology.

[44]  N. Katunuma,et al.  Participation of a cathepsin L-type protease in the activation of caspase-3. , 1999, Cell structure and function.

[45]  Luca Scorrano,et al.  Mitochondria and cell death. Mechanistic aspects and methodological issues. , 1999, European journal of biochemistry.

[46]  A. Rego,et al.  Influence of the antioxidants vitamin E and idebenone on retinal cell injury mediated by chemical ischemia, hypoglycemia, or oxidative stress. , 1999, Free radical biology & medicine.

[47]  H. Hammes,et al.  Differential accumulation of advanced glycation end products in the course of diabetic retinopathy , 1999, Diabetologia.

[48]  M Al-Rubeai,et al.  Use of intracellular pH and annexin-V flow cytometric assays to monitor apoptosis and its suppression by bcl-2 over-expression in hybridoma cell culture. , 1998, Journal of immunological methods.

[49]  S. Pervaiz,et al.  Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu , 1998, FEBS letters.

[50]  R. Funk,et al.  In situ observation of living pericytes in rat retinal capillaries. , 1998, Microvascular research.

[51]  E. Schleicher,et al.  Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. , 1997, The Journal of clinical investigation.

[52]  A. Eastman,et al.  Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. , 1992, Biochemical and biophysical research communications.

[53]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[54]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[55]  A. Ames,et al.  In Vitro Retina as an Experimental Model of the Central Nervous System , 1981, Journal of neurochemistry.

[56]  E. Racker,et al.  Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. , 1979, Biochemistry.

[57]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[58]  P. Cackett,et al.  South-East Scotland trabeculectomy survey , 2007, Eye.

[59]  Fred Hendrikse,et al.  Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. , 2005, Ophthalmology.

[60]  F. Fitzke,et al.  Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. , 2005, Investigative ophthalmology & visual science.

[61]  Nessar Ahmed,et al.  Advanced glycation endproducts--role in pathology of diabetic complications. , 2005, Diabetes research and clinical practice.

[62]  L. Scorrano,et al.  Mitochondria and cell death. Mechanistic aspects and methodological issues. , 1999, European journal of biochemistry.

[63]  P. Riederer,et al.  Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress , 1998, Journal of Neural Transmission.

[64]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.